Prone Position in Non-Invasive Ventilation and High-Flow Oxygen Therapy (ProPNIVFlow)
Primary Purpose
Evaluation of Prone Position Effect During NIV and HFNC on Acute Hypoxemic Respiratory Failure
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Prone position during non-invasive respiratory support
Sponsored by
About this trial
This is an interventional supportive care trial for Evaluation of Prone Position Effect During NIV and HFNC on Acute Hypoxemic Respiratory Failure focused on measuring Noninvasive ventilation, High-flow nasal oxygen therapy, Prone position
Eligibility Criteria
Inclusion Criteria:
Adult patients with:
- ARDS/pneumonia/acute hypoxemic respiratory failure with PaO2/FiO2 between 150 and 300 (on 5 cmH2O PEEP level)
Exclusion Criteria:
- General NIV or HFNC contraindications
- Immediate need for IOT
- Prone position intolerance
- Patients refusal to participate
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Placebo Comparator
Experimental
Placebo Comparator
Arm Label
NIV with prone position
NIV (conventional)
HFNC on prone position
HFNC (conventional)
Arm Description
Use of prone position during NIV
NIV on conventional position
Prone position during HFNC
HFNC on conventional position
Outcomes
Primary Outcome Measures
Oro-tracheal entubation
Oro-tracheal entubation avoidance
Secondary Outcome Measures
PaO2/FiO2
Effect of prone position on PaO2/FiO2
Full Information
NCT ID
NCT04306107
First Posted
March 10, 2020
Last Updated
August 26, 2021
Sponsor
Hospital General Universitario Morales Meseguer
1. Study Identification
Unique Protocol Identification Number
NCT04306107
Brief Title
Prone Position in Non-Invasive Ventilation and High-Flow Oxygen Therapy
Acronym
ProPNIVFlow
Official Title
Prone Position in Non-Invasive Ventilation and High-Flow Oxygen Therapy
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
September 1, 2021 (Anticipated)
Primary Completion Date
November 1, 2021 (Anticipated)
Study Completion Date
May 1, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital General Universitario Morales Meseguer
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this trial is to study the effect of prone position during NIV and HFNC on acute hypoxemic respiratory patients.
Detailed Description
Inclusion Criteria:
Adult patients with:
• ARDS/pneumonia/acute hypoxemic respiratory failure with PaO2/FiO2 between 150 and 300 (on 5 cmH2O PEEP level)
Exclusion Criteria
General NIV or HFNC contraindications
Immediate need for IOT
Prone position intolerance
Patients refusal to participate
Interventions:
Prone position for 2-4 hours twice a day, for 3 days (first 3 days since admission to ICU)
Nurse surveilance: at least every 15 minutes
Outcomes:
Need for IOT
Effects on the measurements specified above (particularly PaO2/FiO2)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Evaluation of Prone Position Effect During NIV and HFNC on Acute Hypoxemic Respiratory Failure
Keywords
Noninvasive ventilation, High-flow nasal oxygen therapy, Prone position
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
NIV with prone position
Arm Type
Experimental
Arm Description
Use of prone position during NIV
Arm Title
NIV (conventional)
Arm Type
Placebo Comparator
Arm Description
NIV on conventional position
Arm Title
HFNC on prone position
Arm Type
Experimental
Arm Description
Prone position during HFNC
Arm Title
HFNC (conventional)
Arm Type
Placebo Comparator
Arm Description
HFNC on conventional position
Intervention Type
Device
Intervention Name(s)
Prone position during non-invasive respiratory support
Other Intervention Name(s)
HFNC and NIV application with patient on prone position
Intervention Description
HFNC and NIV application with patient on prone position
Primary Outcome Measure Information:
Title
Oro-tracheal entubation
Description
Oro-tracheal entubation avoidance
Time Frame
1 month
Secondary Outcome Measure Information:
Title
PaO2/FiO2
Description
Effect of prone position on PaO2/FiO2
Time Frame
1 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult patients with:
ARDS/pneumonia/acute hypoxemic respiratory failure with PaO2/FiO2 between 150 and 300 (on 5 cmH2O PEEP level)
Exclusion Criteria:
General NIV or HFNC contraindications
Immediate need for IOT
Prone position intolerance
Patients refusal to participate
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Miguel Guia, MD
Phone
00351915774975
Ext
00351915774975
Email
miguelguia7@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Prone Position in Non-Invasive Ventilation and High-Flow Oxygen Therapy
We'll reach out to this number within 24 hrs